Skip to main content
. Author manuscript; available in PMC: 2023 Nov 13.
Published in final edited form as: Vaccine. 2022 Jun 3;40(31):4121–4127. doi: 10.1016/j.vaccine.2022.05.077

Table 2.

Estimated proportion of acute respiratory illnesses (ARIs) attributable to RSV based on respiratory viral panel (RVP) tests in health system hospitals*.

Group 3-year average (range), %
Age ≥ 18 years 5.7 (4.3–6.7)
Age ≥ 18 immunocompetent 5.6 (4.2–6.7)
Age 18–64 years 4.1 (2.7–5.3)
Age ≥ 65 years 6.4 (5.1–7.3)
Immunosuppressed (≥18 years) 5.9 (5.0–6.7)
Pregnant (20–44 years) 5.5 (0–7.4)
*

See Appendix 1 Table of ICD codes